BioMaxima S.A. (WSE:BMX)

BioMaxima Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.42	1.74	0.91	1.5	12.91	3
Short-Term Investments	-	-	-	-	0.01	0.01
Cash & Short-Term Investments	0.42	1.74	0.91	1.5	12.92	3.01
Cash Growth	-26.69%	91.09%	-39.52%	-88.37%	329.38%	-31.60%
Accounts Receivable	8.95	6.89	7.35	5.13	8.41	14.79
Other Receivables	4.03	3.8	3.66	3.43	2.08	1.72
Receivables	12.99	10.69	11.01	8.56	10.48	16.51
Inventory	14.79	13.62	13.52	12.77	12.82	14.02
Total Current Assets	28.2	26.04	25.44	22.83	36.23	33.55
Property, Plant & Equipment	49.82	50.37	50.57	50.58	37.66	27.87
Long-Term Investments	-	-	-	-	-	0.01
Other Intangible Assets	0.93	0.56	0.32	0.37	0.44	0.5
Long-Term Deferred Tax Assets	0.5	0.5	0.01	-	-	-
Other Long-Term Assets	-	-	-	-	0.11	-
Total Assets	79.45	77.47	76.34	73.78	74.42	61.93

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.04	4.91	4.25	3.44	6.74	6
Accrued Expenses	2.23	1.98	1.9	1.46	0.65	0.72
Current Portion of Long-Term Debt	10.02	5.37	8.71	3.55	1.31	8.14
Current Portion of Leases	0.75	0.78	0.3	0.25	0.41	0.51
Current Income Taxes Payable	0.05	0.07	0.08	-	-	0.71
Current Unearned Revenue	0.71	0.71	0.7	0.7	0.48	0.48
Other Current Liabilities	1.45	1.16	1.2	1.05	1.39	0.79
Total Current Liabilities	20.24	14.98	17.14	10.44	10.98	17.35
Long-Term Debt	3.63	6.48	5.24	8.61	3.86	8.02
Long-Term Leases	1.73	1.83	0.36	0.46	0.25	0.6
Long-Term Unearned Revenue	5.46	5.64	6.17	6.87	6.02	6.17
Long-Term Deferred Tax Liabilities	0.34	0.34	-	0.33	0.77	0.53
Other Long-Term Liabilities	0.08	0.12	0.1	0.1	0.09	0.06
Total Liabilities	31.49	29.39	29.01	26.81	21.97	32.74

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.19	4.19	4.19	4.19	4.33	4.32
Additional Paid-In Capital	9.84	9.84	9.84	9.84	9.84	9.84
Retained Earnings	32.34	33.3	34.03	33.69	35.02	13.09
Treasury Stock	-	-	-	-	-5	-
Comprehensive Income & Other	1.59	0.74	-0.73	-0.75	8.26	1.95
Total Common Equity	47.96	48.08	47.33	46.97	52.46	29.19
Shareholders' Equity	47.96	48.08	47.33	46.97	52.46	29.19
Total Liabilities & Equity	79.45	77.47	76.34	73.78	74.42	61.93

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	16.12	14.46	14.62	12.86	5.83	17.27
Net Cash (Debt)	-15.7	-12.72	-13.71	-11.36	7.09	-14.26
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.74	-3.03	-3.27	-2.63	1.59	-3.18
Filing Date Shares Outstanding	4.19	4.19	4.19	4.19	4.19	4.33
Total Common Shares Outstanding	4.19	4.19	4.19	4.19	4.15	4.32
Working Capital	7.96	11.06	8.3	12.4	25.25	16.2
Book Value Per Share	11.44	11.47	11.29	11.20	12.65	6.76
Tangible Book Value	47.03	47.52	47.01	46.6	52.02	28.69
Tangible Book Value Per Share	11.22	11.33	11.21	11.11	12.54	6.64
Land	-	1.76	1.76	1.76	3.35	-
Buildings	-	36.28	35.93	35.74	18.26	-
Machinery	-	25.56	24.7	22.44	15.6	-
Construction In Progress	-	0.8	1.11	1.13	8.42	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error